TY -的T1 -初级纤毛dyski评估nesia predictive tools JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.01169-2020 VL - 56 IS - 6 SP - 2001169 AU - Palmas, Kaitlyn AU - Shanthikumar, Shivanthan AU - Robinson, Philip Y1 - 2020/12/01 UR - //www.qdcxjkg.com/content/56/6/2001169.abstract N2 - Primary ciliary dyskinesia (PCD) is an important cause of suppurative airway disease and other comorbidities [1]. Due to nonspecific signs and symptoms, the diagnosis of PCD is challenging, requiring specific expertise [2, 3]. PCD testing should be conducted at specialised PCD centres; however, in many places testing is not readily available. Predictive tools based on clinical presentation would help clinicians triage referral for specialised testing. Two such predictive tools have been developed: the PICADAR score [4] and North American Criteria Defined Clinical Features (NA-CDCF) [5]. There has been little validation of these tools outside the settings where they were developed. The original PICADAR publication contained a constructed validation cohort of 187 patients, half of whom had PCD.A novel real-world validation of two tools (PICADAR and NA-CDCF) that use routinely collected clinical data and help triage the need for primary ciliary dyskinesia diagnostic testing is performed, showing both tools perform well with equivalent performance https://bit.ly/2YgzxlY ER -